Mangalam Drugs & Organics Limited Share Price and Company Fundamentals
Last traded: Today at 9:59 AM
Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, sulfadoxine, tenofovir alafenamide hemifumarate, and tenofovir disoproxil fumarate. It also provides intermediates, such as 2-dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol; 4,6-dichloro-5-methoxy pyrimidine; 4,7 dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base; and tenofovir disoproxil base. In addition, the company offers specialty chemicals comprising l(+)menthol; 2,3-dihydrophthalazine-1, 4-dione or phthalazine-1,4-dione; and 4-cynoethyl-2-methy phenol. Further, it manufactures organic and inorganic chemicals, and heavy chemicals. Additionally, it offers active pharmaceutical ingredients; and products covering various therapeutic areas comprising anti-malaria, anti-retroviral, anti-hypertensive, anti-inflammatory, anti-convulsant, anti-viral, anti-rheumatic arthritis agents, and anti-bacterial, as well as develops product for anti-hypertensive indications. Mangalam Drugs & Organics Limited was incorporated in 1972 and is based in Mumbai, India.
Key Metrics
PE ratio
-
PB ratio
0.39
Dividend yield
-
Beta
0.17
Market cap
₹503.69M
Enterprise value
₹1.48B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 480 |
| Website | https://www.mangalamdrugs.com |
| Mailing address | Rupam Building 3rd Floor 239, P D’ Mello Road Near GPO Mumbai 400001 India |
| Phone / Fax | 91 22 2261 6200 / 91 22 261 9090 |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Mangalam Drugs & Organics Limited paid ₹- dividend and the ex-dividend date was 21 Dec 2017.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MANGALAM dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Mangalam Drugs & Organics Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Govardhan Murlidhar Dhoot | Chairman & MD | 72 | |
| Mr. Brijmohan Murlidhar Dhoot | Whole-Time Director | 74 | |
| Dr. Kamal Ishvarlal Vashi | President | 45 | |
| Ms. Krishnapriya Nawal | Chief Operating Officer | 40 | |
| Mr. Yaduraj Dhoot | Head of Purchase | 25 | |
| Ms. Mansi Sidhinath Pathak | Senior Manager | 46 | |
| Mr. Rakesh Sakikram Srivastava | General Manager | 51 | |
| Dr. Bhanvesh Dinesh Naik | General Manager | 46 |
Profitability and management effectiveness
Profit margin
-13.01%
Operating margin
-10.09%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Mangalam Drugs & Organics Limited is 503.69M and its enterprise value is 1.48B. The enterprise value to revenue ratio of MANGALAM is 0.62. The enterprise value to EBITDA ratio of MANGALAM is 43.92.
The MANGALAM's stocks Beta value is 0.17 making it 83% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Mangalam Drugs & Organics Limited (NSE:MANGALAM) Frequently Asked Questions
1. What is Mangalam Drugs & Organics Limited's Stock Symbol?
Mangalam Drugs & Organics Limited trades on NSE under the ticker symbol "MANGALAM".
2. What is Mangalam Drugs & Organics Limited's stock price today?
One share of MANGALAM stock can currently be purchased for approximately ₹31.73.
3. How can I contact Mangalam Drugs & Organics Limited?
Mangalam Drugs & Organics Limited's mailing address is Rupam Building 3rd Floor 239, P D’ Mello Road Near GPO Mumbai 400001 India. The company can be reached via phone at 91 22 2261 6200.
4. What is Mangalam Drugs & Organics Limited's official website?
The official website of Mangalam Drugs & Organics Limited is https://www.mangalamdrugs.com.